News
12-18-2009, 04:10 AM
Agendia, a world leader in molecular cancer diagnostics, announced that the US Food and Drug Administration (FDA) cleared its MammaPrint breast cancer recurrence test for all ages. MammaPrint is the only FDA-cleared breast cancer recurrence test available to patients and physicians...
More... (http://www.medicalnewstoday.com/articles/174395.php)
More... (http://www.medicalnewstoday.com/articles/174395.php)